Reduced or loss of PTEN function in human gliomas is involved in tumor progression by increasing cell survival, polarity, and motility, and, in addition to tumor grade, it has been correlated with decreased survival time and resistance to radiotherapy, chemotherapy, and immunotherapy in patients with glioma [14,15,16,17,18]. Here, PTEN is linked to glioma.